*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
An in-silico study investigating the differential gene expression of Rho family GTPases and their putative association with HNSCC

Author: AKASH.N , DR.SMILINE GIRIJA A.S, , DR.A.PARAMASIVAM, DR.J.VIJAYASHREE PRIYADHARSINI
Abstract: Rho GTPases are master regulators of actomyosin structure and dynamics and play pivotal roles in a variety of cellular processes including cell morphology, gene transcription, cell cycle progression and cell adhesion. The present study follows an observational study design employing computational tools. The source of patient’s data was procured from the cBioportal database. This database hosts an exhaustive collection of patient’s details from different cohorts. The aberrant expression of Rho GTPase is widely associated with human cancer, which is due to deletion/ addition or amplification of the gene. Gene expression profile and survival analysis was carried out using - UALCAN database. Gene alterations in the Rho GTPase family were identified using - cBioportal. Among 20 genes of the Rho family, five genes RAC2, RAC3, RHOF, RHOG and RHOH were found to exhibit a differential expression pattern with a statistically significant value less than 10-12. The effect of differential gene expression RHOG with different parameters such as grade, gender and race produced statistically significant value less than 0.05. Although, the gene alterations identified in Rho GTPase family genes did not correlate with the oncoprint data, which showed a maximum of 7% alteration in the RHOD gene, the expression pattern of other members of the family in HNSCC patients as documented in the study warrants further investigations to be carried out in these genes.
Keyword: : Rho family, GTPases; Squamous cell carcinomas; actinomycin; cancer.
DOI: https://doi.org/10.31838/ijpr/2020.12.02.314
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free